Your browser doesn't support javascript.
loading
RNA interference against interleukin-5 attenuates airway inflammation and hyperresponsiveness in an asthma model / 浙江大学学报(英文版)(B辑:生物医学和生物技术)
Journal of Zhejiang University. Science. B ; (12): 22-28, 2009.
Artículo en Inglés | WPRIM | ID: wpr-335405
ABSTRACT
Interleukin-5 (IL-5) accompanies the development of airway inflammation and hyperresponsiveness through the activation of eosinophils. Therefore, interference of IL-5 expression in lung tissue seems to be an accepted approach in asthma therapy. In this study, we designed a small interfering RNA (siRNA) to inhibit the expression of IL-5. The siRNAs against IL-5 were constructed in a lentivirus expressing system, and 1.5x10(6) IFU (inclusion-forming unit) lentiviruses were administered intratracheally to ovalbumin (OVA)-sensitized murine asthmatic models. Our results show that lentivirus-delivered siRNA against IL-5 efficiently inhibited the IL-5 messenger ribonucleic acid (mRNA) expression and significantly attenuated the inflammation in lung tissue. Significant decrease of eosinophils and inflammatory cells were found in peripheral blood, bronchoalveolar lavage fluid (BALF), and lung tissue. In addition, significant inhibition of airway hyperresponsiveness (AHR) was found in the mice treated with siRNA against IL-5. These observations demonstrate that siRNA delivered by means of the lentivirus system is possibly an efficacious therapeutic approach for asthma.
Asunto(s)
Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Neumonía / Asma / ARN / Terapia Genética / Interleucina-5 / Resultado del Tratamiento / Hiperreactividad Bronquial / Usos Terapéuticos / Modelos Animales de Enfermedad / Alergia e Inmunología Tipo de estudio: Estudio pronóstico Límite: Animales / Humanos / Masculino Idioma: Inglés Revista: Journal of Zhejiang University. Science. B Año: 2009 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Neumonía / Asma / ARN / Terapia Genética / Interleucina-5 / Resultado del Tratamiento / Hiperreactividad Bronquial / Usos Terapéuticos / Modelos Animales de Enfermedad / Alergia e Inmunología Tipo de estudio: Estudio pronóstico Límite: Animales / Humanos / Masculino Idioma: Inglés Revista: Journal of Zhejiang University. Science. B Año: 2009 Tipo del documento: Artículo